Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Zeppernick

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Iscience|January 26, 2026
Synthetic zipper mediated pre-targeting system for near-infrared photoimmunotherapyT M Mohiuddin, Chaoyu Zhang, Wenjie Sheng, et al.
Human Pathology|September 6, 2017
Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinomaDeyin Xing, Yohan Suryo Rahmanto, Felix Zeppernick, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 24, 2025
A coiled coil-based pre-targeting drug delivery system for precise treatment of breast cancerChaoyu Zhang, Wenjie Sheng, T M Mohiuddin, et al.
Current Issues in Molecular Biology|May 27, 2026
A Customizable Tyramide Signal Amplification-Based Multiplex Immunofluorescence Protocol for FFPE TissuesWenjie Sheng, T M Mohiuddin, Chaoyu Zhang, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation ApproachesAhmad Fawzi Hussain, Armin Grimm, Wenjie Sheng, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
ACS Omega|March 30, 2026
SNAP-Tag-Based Antibody-Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer TreatmentChaoyu Zhang, Wenjie Sheng, T M Mohiuddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Stem cell marker CD133 affects clinical outcome in glioma patientsFelix Zeppernick, Rezvan Ahmadi, Benito Campos, et al.
Frontiers in Medicine|December 4, 2023
Application of the #Enzian classification for endometriosis on MRI: prospective evaluation of inter- and intraobserver agreementSebastian Harth, Hasan Emin Kaya, Felix Zeppernick, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Iscience|January 26, 2026
Synthetic zipper mediated pre-targeting system for near-infrared photoimmunotherapyT M Mohiuddin, Chaoyu Zhang, Wenjie Sheng, et al.
Human Pathology|September 6, 2017
Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinomaDeyin Xing, Yohan Suryo Rahmanto, Felix Zeppernick, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 24, 2025
A coiled coil-based pre-targeting drug delivery system for precise treatment of breast cancerChaoyu Zhang, Wenjie Sheng, T M Mohiuddin, et al.
Current Issues in Molecular Biology|May 27, 2026
A Customizable Tyramide Signal Amplification-Based Multiplex Immunofluorescence Protocol for FFPE TissuesWenjie Sheng, T M Mohiuddin, Chaoyu Zhang, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation ApproachesAhmad Fawzi Hussain, Armin Grimm, Wenjie Sheng, et al.
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
ACS Omega|March 30, 2026
SNAP-Tag-Based Antibody-Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer TreatmentChaoyu Zhang, Wenjie Sheng, T M Mohiuddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Stem cell marker CD133 affects clinical outcome in glioma patientsFelix Zeppernick, Rezvan Ahmadi, Benito Campos, et al.
Frontiers in Medicine|December 4, 2023
Application of the #Enzian classification for endometriosis on MRI: prospective evaluation of inter- and intraobserver agreementSebastian Harth, Hasan Emin Kaya, Felix Zeppernick, et al.
Pageof 5